Shandong leverages capital to advance the "dual carbon" process
New treatments for advanced urothelial cancer show promise in phase 2 clinical trials
Air Products Cummins advances hydrogen fuel truck application
Nat Cancer: Neoadjuvant therapy drugs cabozantinib and nivolumab in the treatment of locally advanced hepatocellular carcinoma
JCEM: Association between the use of antidepressants and the outcome of advanced diabetes in patients with depression and diabetes
Obesity can increase the survival rate of patients with advanced prostate cancer
Lancet Sub-Journal: Radiotherapy does not help patients with advanced esophageal cancer with dysphagia!
J Clin Oncol: The perioperative addition of duvacizumab in patients with advanced NSCLC significantly increased the 1-year EFS rate
J Clin Oncol: Efficacy and safety of CMB305 combined with atezolizumab in the treatment of locally advanced synovial sarcoma or myxoid liposarcoma
Clin Cancer Res: Efficacy and safety of PARPi Veliparib combined with carboplatin and etoposide in the treatment of advanced small cell lung cancer
Science Advances: Plants can also be "remote control"
IEEE trans: Use fNIRS-based BCI system to strengthen communication between patients with advanced ALS
Science Advances: Do not break or stand?
-line treatment of advanced non-squamous non-small cell lung cancer (NSCLC): an indirect comparative analysis of matching adjustment
for precise treatment of patients with advanced solid tumors!
Advanced Science Bai Fan's research group and collaborators reveal the high heterogeneity of IDH
Lung Cancer: Treatment of advanced non-small cell lung cancer with KRAS G12C mutation: a real
Lancet respirat: Phase 3 clinical trial of Tongji University reveals the efficacy of icotinib in EGFR-mutant advanced NSCLC
TDM1 treatment of six-line advanced breast cancer patients, MRG002 treatment rapid PR MRG002 brings new hope to HER2-positive breast cancer patients
of Ipilimumab in the treatment of advanced melanoma: KEYNOTE-029 cohort 1C.